OncoTartis Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:OncoTartis Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013538
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OncoTartis Inc (OncoTartis) is a biotechnology company with a focus on development of various treatments for various types of cancers. Its lead candidate OT-82, an orally available NicotinAMide Phosphoribosyl Transferase inhibitor, is being developed for treating broad range of leukemias and lymphomas. The company utilizes, Tartis, proprietary integrated drug and target discovery platform for identification of small molecules and shRNAs compounds corresponding to specific genes. OncoTartis’s products find application in treating breast, prostate, ovarian, melanoma and hematological malignancies. It carries research and development activities in both chemical and biological screenings with specific focus on cell phenotype-based readout systems. OncoTartis is headquartered in Buffalo, New York, the US.

OncoTartis Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OncoTartis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
OncoTartis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
OncoTartis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
OncoTartis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
OncoTartis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
OncoTartis Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
OncoTartis Raises USD1.85 in Series B Financing 10
OncoTartis Raises USD6.4 in Series A Financing 11
Licensing Agreements 12
OncoTartis Enters into Licensing Agreement with Roswell Park Cancer Institute 12
OncoTartis Inc – Key Competitors 13
OncoTartis Inc – Key Employees 14
OncoTartis Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
OncoTartis Inc, Pharmaceuticals & Healthcare, Key Facts 2
OncoTartis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
OncoTartis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
OncoTartis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
OncoTartis Inc, Deals By Therapy Area, 2011 to YTD 2017 8
OncoTartis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
OncoTartis Raises USD1.85 in Series B Financing 10
OncoTartis Raises USD6.4 in Series A Financing 11
OncoTartis Enters into Licensing Agreement with Roswell Park Cancer Institute 12
OncoTartis Inc, Key Competitors 13
OncoTartis Inc, Key Employees 14

★海外企業調査レポート[OncoTartis Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Triumph Group Inc:企業の戦略・SWOT・財務情報
    Triumph Group Inc - Strategy, SWOT and Corporate Finance Report Summary Triumph Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • J.B. Hunt Transport Services, Inc. (JBHT):企業の財務・戦略的SWOT分析
    J.B. Hunt Transport Services, Inc. (JBHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • ULURU Inc (ULUR)-医療機器分野:企業M&A・提携分析
    Summary ULURU Inc (ULURU) is a developer and commercializer of wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wounds. ULURU’s OraDisc is a polymer …
  • J.F. Shea Co Inc:企業の戦略・SWOT・財務分析
    J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report Summary J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Fonterra Co-operative Group Ltd:企業の戦略・SWOT・財務分析
    Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Oncopeptides AB (ONCO):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncopeptides AB (Oncopeptides) is a clinical development pharmaceutical company that offers development of oncology therapies to treat multiple myeloma. The company’s lead product candidate Ygalo (melflufen) is a peptidase potentiated cytotoxic drug and a potent anti-angiogenetic compound, a …
  • Koninklijke Philips NV (PHIA):企業の製品パイプライン分析
    Summary Koninklijke Philips NV (Philips) is a diversified technology company that develops and manufactures medical systems and consumer electronics products. The company offers products and solutions in the areas of diagnostic imaging, enterprise diagnostic informatics, image-guided therapy, ultras …
  • HealthEquity Inc (HQY):企業の財務・戦略的SWOT分析
    Summary HealthEquity Inc (HealthEquity) is a healthcare service provider that offers health savings management services. The company provides integrated health accounts such as health savings account, health reimbursement arrangements, flexible spending accounts for health plans, insurance companies …
  • Ube Industries, Ltd.:企業の戦略・SWOT・財務情報
    Ube Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ube Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • GAIL (India) Limited:企業の戦略・SWOT・財務分析
    GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report Summary GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MicroPort Scientific Corp (853)-医療機器分野:企業M&A・提携分析
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company that develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, el …
  • Hoteis Othon SA:企業の戦略・SWOT・財務情報
    Hoteis Othon SA - Strategy, SWOT and Corporate Finance Report Summary Hoteis Othon SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Shinva Medical Instrument Co Ltd (600587):企業の財務・戦略的SWOT分析
    Shinva Medical Instrument Co Ltd (600587) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • NanoVibronix Inc (NAOV):製品パイプライン分析
    Summary NanoVibronix Inc (NanoVibronix) is a medical device company that offers therapeutic ultrasound technology solutions. The company offers clinical applications such as catheter related injury and its complications, pain and soft tissue healing. It offers electronic unit that uses disposable pa …
  • Ocean Power Technologies Inc (OPTT):電力:M&Aディール及び事業提携情報
    Summary Ocean Power Technologies, Inc. (OPT) is a provider of ocean energy solutions. The company harnesses the abundant wave power to draw out renewable energy; and commercializes ocean wave power conversion technology products. The company's PB3 PowerBuoy integrates patented technologies in hydrod …
  • Ocular Therapeutix Inc (OCUL):企業の財務・戦略的SWOT分析
    Summary Ocular Therapeutix Inc (Ocular Therapeutix), formerly I-Therapeutix Inc, is a biopharmaceutical company that discovers, develops and commercializes therapies for treating eye diseases. The company’s lead product candidate DEXTENZA is used for the treatment of post-surgical ocular inflammatio …
  • Marksans Pharma Ltd (MARKSANS):企業の財務・戦略的SWOT分析
    Summary Marksans Pharma Ltd (Marksans Pharma) is a pharmaceutical company that develops, manufactures and markets branded formulations and generic products. The company manufactures non-sterile liquids, ointments and powder products. It offers solid oral dosage in form of tablets, hard gelatin capsu …
  • Probiogen AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Probiogen AG (Probiogen) a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeut …
  • Ascential plc (formerly Top Right Group Limited):企業のM&A・事業提携・投資動向
    Ascential plc (formerly Top Right Group Limited) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ascential plc (formerly Top Right Group Limited) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • Qsc AG (QSC):企業の財務・戦略的SWOT分析
    Summary Qsc AG (Qsc) is a telecommunication company that provides integrated telecommunication and managed services. The company offers services such as cloud and IT outsourcing, Internet of Things services, sap services and consulting, broadband and network services, and colocation services. Its cl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆